Search

Your search keyword '"Armstrong DG"' showing total 916 results

Search Constraints

Start Over You searched for: Author "Armstrong DG" Remove constraint Author: "Armstrong DG"
916 results on '"Armstrong DG"'

Search Results

201. Decoding foot deformity and joint-destruction pathways in diabetes: Emerging insights from in-vivo foot joint kinetic measures.

202. Diabetic foot disease in subjects with End-stage renal Disease: A nationwide study over 14 years highlighting an emerging threat.

203. A Multicenter, Randomized, Controlled, Clinical Trial Evaluating Dehydrated Human Amniotic Membrane in the Treatment of Venous Leg Ulcers.

204. Does Routine Subspecialty Consultation Before High-Risk Pediatric Spine Surgery Decrease the Incidence of Complications?

205. Cost of Treatment of Neuroischemic Ulcers of the Lower Extremity in Patients with Peripheral Artery Disease in the United States.

206. Autologous Minimally Manipulated Homologous Adipose Tissue (AMHAT) for Treatment of Nonhealing Diabetic Foot Ulcers.

207. Deriving International Classification of Diseases, 9th and 10th revision, codes for identifying and following up patients with diabetic lower extremity ulcers.

208. The amputation and mortality of inpatients with diabetic foot ulceration in the COVID-19 pandemic and postpandemic era: A machine learning study.

209. Late presenting developmental dysplasia of the hip after a normal hip ultrasound at 6 weeks of age: A report of two cases.

211. The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: Current perspectives and future challenges.

212. Potential Utility of Ultrasound-Enhanced Delivery of Antibiotics, Anti-Inflammatory Agents, and Nutraceuticals: A Mini Review.

213. Outcomes of Hallux Amputation Versus Partial First Ray Resection in People with Non-Healing Diabetic Foot Ulcers: A Pragmatic Observational Cohort Study.

214. Evolution of WIfI: Expansion of WIfI Notation After Intervention.

215. Metagenomics of diabetic foot ulcer undergoing treatment with total contact casting: a case study.

216. Impact of acute hyperglycemic crisis episode on survival in individuals with diabetic foot ulcer using a machine learning approach.

217. A qualitative study of barriers to care-seeking for diabetic foot ulceration across multiple levels of the healthcare system.

218. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.

220. Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy.

221. A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.

222. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.

223. An explainable machine learning model for predicting in-hospital amputation rate of patients with diabetic foot ulcer.

225. New Evidence-Based Therapies for Complex Diabetic Foot Wounds

226. Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.

227. Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft.

228. An Evaluation of Real-world Smart Sock-Based Temperature Monitoring Data as a Physiological Indicator of Early Diabetic Foot Injury: Case-Control Study.

229. Rates of Diabetes-Related Major Amputations Among Racial and Ethnic Minority Adults Following Medicaid Expansion Under the Patient Protection and Affordable Care Act.

230. Chronic wounds: Treatment consensus.

232. Time in range in relation to amputation and all-cause mortality in hospitalised patients with diabetic foot ulcers.

233. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment.

234. Higher rates of all-cause mortality and resource utilization during episodes-of-care for diabetic foot ulceration.

235. Neurophysiological Intraoperative Monitoring in Patients with Cochlear Implant Undergoing Posterior Spinal Fusion: A Case Report.

236. A multicentre, randomised controlled clinical trial evaluating the effects of a novel autologous, heterogeneous skin construct in the treatment of Wagner one diabetic foot ulcers: Interim analysis.

237. Survival of Patients Following First Diagnosis of Diabetic Foot Complications: A Nationwide 15-Year Longitudinal Analysis.

238. MRI nomenclature for musculoskeletal infection.

240. Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients.

241. Staged salvage of diabetic foot with Chopart amputation and intramedullary nailing.

242. Dosing Activity and Return to Preulcer Function in Diabetes-Related Foot Ulcer Remission.

243. Compartment Syndrome in Children With a Supracondylar Fracture: Not Everyone has Risk Factors.

245. Wound Healing Driver Gene and Therapeutic Development: Political and Scientific Hurdles.

246. Opportunities for diabetes and peripheral artery disease-related lower limb amputation prevention in an Appalachian state: A longitudinal analysis.

247. Observed impact of skin substitutes in lower extremity diabetic ulcers: lessons from the Medicare Database (2015-2018).

248. Development and validation of a pocket guide for the prevention of diabetic foot ulcers.

249. Molecular Biomarkers of Oxygen Therapy in Patients with Diabetic Foot Ulcers.

250. Nationwide prevalence and clinical characteristics of inpatient diabetic foot complications: A Peruvian multicenter study.

Catalog

Books, media, physical & digital resources